Worldwide variations in EGFR somatic mutations: a challenge for personalized medicine

Por Lamy, Pierre-Jean, Jacot, William
Publicado em 2012

TOP2A Amplification in Breast Cancer in the Absence of That of HER-2: Myth or Reality?

Por Lamy, Pierre-Jean, Jacot, William
Publicado em 2012

Severe Peritonitis Induced by Methotrexate During Treatment of Persistent Gestational Trophoblastic Disease

Por Zimmermann, Stefan, Zaman, Khalil, Wolfer, Anita, Jacot, William
Publicado em 2012

Anti-HER2 vaccines: new prospects for breast cancer therapy

Por Ladjemi, Maha Zohra, Jacot, William, Chardès, Thierry, Pèlegrin, André, Navarro-Teulon, Isabelle
Publicado em 2010

Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases

Por Braccini, Antoine-Laurent, Azria, David, Thezenas, Simon, Romieu, Gilles, Ferrero, Jean-Marc, Jacot, William
Publicado em 2013

Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study

Por Jacot, William, Gerlotto-Borne, Marie-Cécile, Thezenas, Simon, Pouderoux, Stéphane, Poujol, Sylvain, About, Mahdi, Romieu, Gilles
Publicado em 2010

Comparison of Supervised Classification Methods for Protein Profiling in Cancer Diagnosis

Por Dossat, Nadège, Mangé, Alain, Solassol, Jérôme, Jacot, William, Lhermitte, Ludovic, Maudelonde, Thierry, Daurès, Jean-Pierre, Molinari, Nicolas
Publicado em 2007

Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles

Por Jacot, William, Lopez-Crapez, Evelyne, Thezenas, Simon, Senal, Romain, Fina, Frédéric, Bibeau, Frédéric, Romieu, Gilles, Lamy, Pierre-Jean
Publicado em 2011

Age and stage at diagnosis: a hospital series of 11 women with intellectual disability and breast carcinoma

Por Satgé, Daniel, Sauleau, Eric-André, Jacot, William, Raffi, Fernand, Azéma, Bernard, Bouyat, Jean-Claude, El Hage Assaf, Nicolas
Publicado em 2014

CBM-07 SERUM NSE, MMP-9 AND HER2 ARE PREDICTIVE OF BRAIN METASTASES IN METASTATIC BREAST CANCER PATIENTS

Por Darlix, Amélie, Lamy, Pierre-Jean, Crapez, Evelyne, Braccini, Antoine Laurent, Firmin, Nelly, Romieu, Gilles, Thezenas, Simon, Jacot, William
Publicado no Neuro Oncol (2015)

Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers

Por Lamy, Pierre-Jean, Fina, Frédéric, Bascoul-Mollevi, Caroline, Laberenne, Anne-Claire, Martin, Pierre-Marie, Ouafik, L'Houcine, Jacot, William
Publicado em 2011

Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients

Por Darlix, Amélie, Lamy, Pierre-Jean, Lopez-Crapez, Evelyne, Braccini, Antoine Laurent, Firmin, Nelly, Romieu, Gilles, Thezenas, Simon, Jacot, William
Publicado no BMC Cancer (2016)

Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer

Por Alix-Panabières, Catherine, Vendrell, Jean-Pierre, Slijper, Monique, Pellé, Olivier, Barbotte, Eric, Mercier, Grégoire, Jacot, William, Fabbro, Michel, Pantel, Klaus
Publicado em 2009

Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer

Por El Demery, Mounira, Demirdjian-Sarkissian, Gaiané, Thezenas, Simon, Jacot, William, Laghzali, Yassine, Darbouret, Bruno, Culine, Stéphane, Rebillard, Xavier, Lamy, Pierre-Jean
Publicado no Clin Transl Med (2014)

Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multi...

Por Dell’Ova, Mélodie, De Maio, Eléonora, Guiu, Séverine, Roca, Lise, Dalenc, Florence, Durigova, Anna, Pinguet, Frédéric, Bekhtari, Khedidja, Jacot, William, Pouderoux, Stéphane
Publicado no BMC Cancer (2015)

High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancers

Por Jacot, William, Mollevi, Caroline, Fina, Frédéric, Lopez-Crapez, Evelyne, Martin, Pierre-Marie, Colombo, Pierre-Emmanuel, Bibeau, Frédéric, Romieu, Gilles, Lamy, Pierre-Jean
Publicado no BMC Cancer (2015)

BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer

Por Jacot, William, Thezenas, Simon, Senal, Romain, Viglianti, Cathy, Laberenne, Anne-Claire, Lopez-Crapez, Evelyne, Bibeau, Frédéric, Bleuse, Jean-Pierre, Romieu, Gilles, Lamy, Pierre-Jean
Publicado no BMC Cancer (2013)

Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice

Por Ladjemi, Maha Z, Chardes, Thierry, Corgnac, Stephanie, Garambois, Veronique, Morisseau, Sebastien, Robert, Bruno, Bascoul-Mollevi, Caroline, Ait Arsa, Imade, Jacot, William, Pouget, Jean-Pierre, Pelegrin, Andre, Navarro-Teulon, Isabelle
Publicado em 2011

Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing

Por Fusco, Nicola, Colombo, Pierre-Emmanuel, Martelotto, Luciano G., De Filippo, Maria R., Piscuoglio, Salvatore, Ng, Charlotte K.Y., Lim, Raymond S., Jacot, William, Vincent-Salomon, Anne, Reis-Filho, Jorge S., Weigelt, Britta
Publicado no Histopathology (2015)

Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Resul...

Por Gligorov, Joseph, Pivot, Xavier B., Jacot, William, Naman, Hervé L., Spaeth, Dominique, Misset, Jean-Louis, Largillier, Rémy, Sautiere, Jean-Loup, de Roquancourt, Anne, Pomel, Christophe, Rouanet, Philippe, Rouzier, Roman, Penault-Llorca, Frederique M.
Publicado no Oncologist (2015)